Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771195015 | Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3771196019 | Physostigmine and pilocarpine only product in ocular dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Plays role | Antiglaucoma therapeutic role | true | Inferred relationship | Some | ||
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Is a | Product containing only physostigmine and pilocarpine (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Has manufactured dose form | Ocular dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Is a | Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Has active ingredient | Physostigmine (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Has active ingredient | Pilocarpine (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) | Is a | True | Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Inferred relationship | Some | |
| Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution | Is a | True | Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) | Is a | True | Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR